Clinical Trials Logo

Tobacco Use Cessation clinical trials

View clinical trials related to Tobacco Use Cessation.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06042361 Enrolling by invitation - Clinical trials for Tobacco Use Disorder

Enhancing Equity in Smoke-free Housing

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the acceptability, feasibility, and effectiveness of smoke-free housing policy implementation in Permanent Supportive Housing communities. The main objective of this study is to identify and refine adaptations for a smoke-free housing implementation framework that incorporates behavioral health support and meets the needs of residents living in Permanent Supportive Housing.

NCT ID: NCT05952401 Enrolling by invitation - Smoking Cessation Clinical Trials

Implementation Science to Reduce the Disparity in Tobacco Treatment Among Individuals With Serious Mental Illness

ISRAISE
Start date: May 31, 2024
Phase: N/A
Study type: Interventional

This is a pilot trial to examine the feasibility and preliminary effect of a multilevel intervention 'Nudges to Quit' on smoking cessation in patients with serious mental illness who smoke in a community mental health center (CMHC). "Nudges to Quit" is a multilevel intervention to increate engagement of patient, case worker, and pharmacist with tobacco treatment. The pilot trial is to generate the needed evidence for designing a future large trial to evaluate the effect of 'Nudges to Quit' as a multilevel intervention to increase tobacco treatment and reduce tobacco use among patients with serious mental illness.

NCT ID: NCT05627674 Enrolling by invitation - Smoking Cessation Clinical Trials

Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment

PRECISE
Start date: January 1, 2023
Phase: N/A
Study type: Interventional

This trial tests the effects of two versions of RiskProfile, a clinically-informed and a genetically-informed version of a patient-specific risk feedback tool, in comparison to usual care, on lung cancer screening and tobacco treatment. The trial assesses the multilevel effects of these precision risk feedback tools on the likelihood of clinicians to order lung cancer screening and tobacco treatment and of their patients to utilize these cancer prevention interventions.

NCT ID: NCT03979885 Enrolling by invitation - Smoking Cessation Clinical Trials

Financial Incentives for Smoking Treatment II

FIESTA II
Start date: January 6, 2020
Phase: N/A
Study type: Interventional

Financial incentives for motivating changes in health behavior, particularly for smoking and other morbid habits, are increasingly being tested by health insurers, employers, and government agencies. However, in using incentive programs for smoking cessation, key unanswered structural and theoretical questions remain regarding their effectiveness, acceptability to patients, and economic sustainability. This trial aims to advance the science and implementation of financial incentives for smoking cessation interventions among high-risk, hospitalized smokers. The investigators will pursue two specific aims: 1) comparing the impact of three approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life and 2) comparing the short-term and long term return on investment of using goal directed and outcome-based financial incentives to promote smoking cessation.